11.64
전일 마감가:
$11.63
열려 있는:
$11.63
하루 거래량:
77,190
Relative Volume:
0.59
시가총액:
$96.98M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Company Profile
명칭
Retension Pharmaceuticals, Inc. Common Stock
전화
-
주소
-
Compare RTSN vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
RTSN
Retension Pharmaceuticals, Inc. Common Stock
|
11.64 | 96.98M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Retension Pharmaceuticals, Inc. Common Stock 주식(RTSN)의 최신 뉴스
With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan
CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan
Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
Total common shares outstanding of RETENSION PHARMACEUTICALS INC – NASDAQ:RTSN - TradingView
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest press releases and corporate news - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) analyst ratings, estimates and forecasts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) cash flow - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock historical prices and data - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) company profile and facts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) options chain - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
RTSN Interactive Stock Chart | Retension Pharmaceuticals, Inc. Common Stock Stock - Yahoo Finance
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Ratings, Estimates & ForecastsYahoo Finance - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest stock news and headlines - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) interactive stock chart - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock major holders - Yahoo Finance UK
Retension Pharmaceuticals Announces Pricing of Initial Public Offering - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price, news, quote and history - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) 재무 분석
Retension Pharmaceuticals, Inc. Common Stock (RTSN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Retension Pharmaceuticals, Inc. Common Stock 주식 (RTSN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Oct 13 '26 |
Buy |
12.00 |
10,000 |
120,000 |
10,000 |
자본화:
|
볼륨(24시간):